Literature DB >> 5339229

The medical sequelae of narcotic addiction.

C E Cherubin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5339229     DOI: 10.7326/0003-4819-67-1-23

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  29 in total

1.  Is methadone a miracle cure or an alternative evil?

Authors:  R S Hoffman
Journal:  West J Med       Date:  2000-01

2.  Satisfaction with access to health care among injection drug users, other drug users, and nonusers.

Authors:  Dale D Chitwood; Mary Comerford; H Virginia McCoy
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

3.  Methadone programmes. The costs and benefits to society and the individual.

Authors:  G E Ralston; P Wilson
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

Review 4.  Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

Review 5.  Naloxone in opioid poisoning: walking the tightrope.

Authors:  S F J Clarke; P I Dargan; A L Jones
Journal:  Emerg Med J       Date:  2005-09       Impact factor: 2.740

6.  Aggravation by morphine and D-aspartic acid of pyelonephritis induced by i.v. inoculation of Staphylococcus aureus in rats.

Authors:  H Koyuncuoğlu; M Güngör; O Anğ; D Inanç; M Anğ-Küçüker; H Sağduyu; V Uysal
Journal:  Infection       Date:  1988       Impact factor: 3.553

7.  Injection drug use, mortality, and the AIDS epidemic.

Authors:  P A Selwyn
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

Review 8.  Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

9.  Experimental hematogenous Candida endophthalmitis: diagnostic approaches.

Authors:  D K Henderson; J E Edwards; K Ishida; L B Guze
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Immunomodulatory activity of mu- and kappa-selective opioid agonists.

Authors:  D D Taub; T K Eisenstein; E B Geller; M W Adler; T J Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.